118 related articles for article (PubMed ID: 3054922)
1. Ornithine decarboxylase as a marker for colorectal polyps and cancer.
Luk GD; Moshier JA; Ehrinpreis MN
Prog Clin Biol Res; 1988; 279():227-39. PubMed ID: 3054922
[TBL] [Abstract][Full Text] [Related]
2. Ornithine decarboxylase: an unreliable marker for the identification of population groups at risk for colonic neoplasia.
Braverman DZ; Stankiewicz H; Goldstein R; Patz JK; Morali GA; Jacobsohn WZ
Am J Gastroenterol; 1990 Jun; 85(6):723-6. PubMed ID: 2353692
[TBL] [Abstract][Full Text] [Related]
3. Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.
Hixson LJ; Garewal HS; McGee DL; Sloan D; Fennerty MB; Sampliner RE; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):369-74. PubMed ID: 8348060
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers in colorectal cancer: diagnostic and therapeutic implications.
Luk GD; Desai TK; Conteas CN; Moshier JA; Silverman AL
Gastroenterol Clin North Am; 1988 Dec; 17(4):931-40. PubMed ID: 3068151
[TBL] [Abstract][Full Text] [Related]
5. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolyposis hereditary colorectal cancer, and adenomas.
Love RR; Surawicz TS; Morrissey JF; Verma AK
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):195-8. PubMed ID: 1306105
[TBL] [Abstract][Full Text] [Related]
6. Ornithine decarboxylase as a biologic marker in familial colonic polyposis.
Luk GD; Baylin SB
N Engl J Med; 1984 Jul; 311(2):80-3. PubMed ID: 6738598
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers in patients with familial colonic neoplasia.
Luk GD; Silverman AL; Giardiello FM
Semin Surg Oncol; 1987; 3(2):126-32. PubMed ID: 3035686
[TBL] [Abstract][Full Text] [Related]
8. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
9. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
[TBL] [Abstract][Full Text] [Related]
11. Supplemental calcium suppresses colonic mucosal ornithine decarboxylase activity in elderly patients with adenomatous polyps.
Lans JI; Jaszewski R; Arlow FL; Tureaud J; Luk GD; Majumdar AP
Cancer Res; 1991 Jul; 51(13):3416-9. PubMed ID: 1711410
[TBL] [Abstract][Full Text] [Related]
12. Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma.
Matsubara N; Hietala OA; Gilmour SK; Yum KY; Litwin S; Watts P; Brennan ; O'Brien
Clin Cancer Res; 1995 Jun; 1(6):665-71. PubMed ID: 9816030
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
Gebauer G; Müller-Ruchholtz W
Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011
[TBL] [Abstract][Full Text] [Related]
16. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
Biasco G; Paganelli GM; Santucci R; Brandi G; Barbara L
J Cell Biochem Suppl; 1994; 19():55-60. PubMed ID: 7823606
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon.
von Kleist S; Hesse Y; Kananeeh H
Anticancer Res; 1996; 16(4B):2325-31. PubMed ID: 8694564
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers in gastrointestinal cancer and its clinical significance].
Taguchi T; Ota J; Sumida S; Rii M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
20. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
Grotowski M
Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
